Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,953 Million (Mid Cap)
73.00
NA
0.20%
0.03
9.86%
2.99
Revenue and Profits:
Net Sales:
430 Million
(Quarterly Results - Dec 2025)
Net Profit:
34 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.8%
0%
-8.8%
6 Months
-22.59%
0%
-22.59%
1 Year
58.03%
0%
58.03%
2 Years
26.83%
0%
26.83%
3 Years
74.05%
0%
74.05%
4 Years
65.5%
0%
65.5%
5 Years
0%
0%
0.0%
Hunan Warrant Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.16%
EBIT Growth (5y)
-12.42%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.74
Tax Ratio
11.03%
Dividend Payout Ratio
24.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.36%
ROE (avg)
12.38%
Valuation key factors
Factor
Value
P/E Ratio
73
Industry P/E
Price to Book Value
4.04
EV to EBIT
77.97
EV to EBITDA
42.40
EV to Capital Employed
4.70
EV to Sales
5.21
PEG Ratio
NA
Dividend Yield
0.16%
ROCE (Latest)
6.03%
ROE (Latest)
5.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
429.80
336.00
27.92%
Operating Profit (PBDIT) excl Other Income
28.60
16.00
78.75%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
34.30
-0.60
5,816.67%
Operating Profit Margin (Excl OI)
66.60%
-7.50%
7.41%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 27.92% vs -9.09% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 5,816.67% vs -101.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,515.60
1,387.20
9.26%
Operating Profit (PBDIT) excl Other Income
245.10
204.50
19.85%
Interest
0.00
0.30
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
241.50
138.80
73.99%
Operating Profit Margin (Excl OI)
161.70%
95.50%
6.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 9.26% vs -1.86% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 73.99% vs -28.08% in Dec 2024
About Hunan Warrant Pharmaceutical Co., Ltd. 
Hunan Warrant Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






